Bain Capital Specialty Finance, Inc. BCSF
NYSE · United States · Finance
$11.04-0.19 (-1.69%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
The fair value estimate for Bain Capital Specialty Finance has shifted lower, moving from US$13.83 to US$12.67 as part of the latest analyst update. This adjustment aligns with Street research that now clusters price targets around US$12 to US$13. It reflects a balance between solid liquidity and concerns around net asset value, credit quality, and refinancing costs. As you read on, you will see how this evolving narrative may shape expectations and what to watch next around Bain Capital...
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
BCSF reports strong dividend coverage and attractive new investment spreads, while navigating modest credit deterioration and a higher leverage ratio.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.